| RS367543029 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS367543030 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS367543031 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS367543032 |
BLM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS367543033 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS367543034 |
BLM
|
Health Risk |
Likely pathogenic |
Bloom syndrome, Bloom syndrome |
| RS367543035 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS367543036 |
BLM
|
Health Risk |
Likely pathogenic |
Bloom syndrome, Bloom syndrome |
| RS367543038 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS367543039 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS367543041 |
TARDBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 10, FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS |
| RS367543043 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Hereditary breast ovarian cancer syndrome |
| RS367543046 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Fumarase deficiency, Hereditary cancer-predisposing syndrome |
| RS367543048 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myopathy with fiber type disproportion, Actin accumulation myopathy |
| RS367543049 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myopathy with fiber type disproportion, Actin accumulation myopathy |
| RS367543052 |
MYH7
|
Health Risk |
Pathogenic |
Congenital myopathy with fiber type disproportion, MYH7-related skeletal myopathy |
| RS367543055 |
RYR1
|
Health Risk |
Pathogenic |
Congenital myopathy with fiber type disproportion, RYR1-related disorder |
| RS367543058 |
RYR1
|
Health Risk |
Pathogenic |
Congenital myopathy with fiber type disproportion, Central core myopathy |
| RS367543059 |
SLC16A2
|
Health Risk |
Likely pathogenic |
Allan-Herndon-Dudley syndrome, Allan-Herndon-Dudley syndrome |
| RS367543061 |
CPLANE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 17, Joubert syndrome and related disorders |
| RS367543062 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome 17, Orofaciodigital syndrome type 6 |
| RS367543063 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome 17, Orofaciodigital syndrome type 6 |
| RS367543064 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome 17, Joubert syndrome 17 |
| RS367543065 |
TCTN1
|
Health Risk |
Pathogenic |
Joubert syndrome 13, Joubert syndrome 13 |
| RS367543066 |
TYR
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 1A, Oculocutaneous albinism type 1B |
| RS367543067 |
TYR
|
Health Risk |
Likely pathogenic |
— |
| RS367543068 |
TYR
|
Health Risk |
Pathogenic/Likely pathogenic |
Oculocutaneous albinism type 1A, Oculocutaneous albinism type 1B |
| RS367543069 |
B3GALNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS367543070 |
B3GALNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS367543072 |
B3GALNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS367543073 |
B3GALNT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS367543075 |
B3GALNT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS367543076 |
B3GALNT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS367543077 |
B3GALNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS367543120 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS367543124 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Inborn genetic diseases |
| RS367543132 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS367543145 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Inborn genetic diseases |
| RS367543256 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS367543258 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Galactosemia |
| RS367543260 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS367543262 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS367543263 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS367543266 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Galactosemia |
| RS367543267 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS367543268 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS367543271 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS367543272 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS367543273 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS367543282 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS367543284 |
SH3PXD2B
|
Health Risk |
Pathogenic |
Frank-Ter Haar syndrome, Frank-Ter Haar syndrome |
| RS367543285 |
NOTCH3
|
Health Risk |
Pathogenic |
Myofibromatosis, infantile |
| RS367543286 |
PDGFRB
|
Health Risk |
Pathogenic |
Myofibromatosis, infantile |
| RS367543496 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, 6 conditions |
| RS367543552 |
RORB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS367543871 |
EXT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS367544716 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS367545984 |
VHL
|
Health Risk |
Likely pathogenic |
— |
| RS367546131 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS367546924 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS367547063 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolfram syndrome 1, Wolfram-like syndrome |
| RS367547253 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Luscan-Lumish syndrome |
| RS367548433 |
TPM3
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myopathy with fiber type disproportion, Congenital myopathy 4B |
| RS367548480 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS367548624 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS367549284 |
IMPDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Leber congenital amaurosis 11 |
| RS367549881 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS367549998 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Early-onset myopathy with fatal cardiomyopathy |
| RS367550855 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Inborn genetic diseases |
| RS367551573 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Autosomal dominant cerebellar ataxia |
| RS367552151 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS367553206 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS367553801 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS367556839 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory and autonomic |
| RS367557471 |
CHD7
|
Health Risk |
Likely pathogenic |
Atrial septal defect, Pyloric stenosis |
| RS367558510 |
GALK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS367559440 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS367559858 |
AGAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS367560074 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 4A, Autosomal dominant nonsyndromic hearing loss 4A |
| RS367560131 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS367560509 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS367560550 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS367560743 |
GNRHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 7 with or without anosmia, Hypogonadotropic hypogonadism 7 with or without anosmia |
| RS367560855 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS367563077 |
MEIS2
|
Health Risk |
Likely pathogenic |
Cardiac malformation, cleft lip/palate |
| RS367563723 |
JPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS367564272 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Familial cancer of breast |
| RS367564566 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS367565995 |
RAPSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS367566671 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS367567416 |
GAMT
|
Health Risk |
Likely pathogenic |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS367567630 |
CLCN7
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive osteopetrosis 4, Autosomal recessive osteopetrosis 4 |
| RS367568223 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS367568441 |
VCL
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1W, Cardiovascular phenotype |
| RS367569053 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS367569299 |
F9
|
Health Risk |
Benign; association |
Hereditary factor IX deficiency disease, Warfarin sensitivity |
| RS367570129 |
ALG14
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 15, Congenital myasthenic syndrome 15 |
| RS367570298 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Short QT syndrome type 1 |
| RS367570778 |
TRMU
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, TRMU-related disorder |
| RS367572249 |
SDCCAG8
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 16, Bardet-Biedl syndrome 16 |